← Leaderboards
Raquibul Hannan
Ut Southwestern Medical Center
$1,988,883
Attributed
$2,699,127
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $683.7K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,699,127 · 2
By mechanism
R01$1,420,489 · 1
P50$1,278,638 · 1
Top collaborators
- Jing Wang4 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Ivan Pedrosa$7,238,451
- Payal Kapur$5,256,250
- Ananth J Madhuranthakam$2,882,549
- Dawen Zhao$3,249,655
- Wen Jiang$5,217,879
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorCancer PatientImproved OutcomeRadiationBiopsyInnovationToxic EffectTissuesDose-LimitingAntigen PresentationBiological AvailabilityAnatomyBiological SciencesAdaptive Immune ResponseCostBenignCancer Radiation TherapyBaseAnalogClinical TrialsCohortCommunitiesBiochemicalBlood Vessels
Grant awards (8)
Project 3: Maximizing Anti-tumor Activity through Simultaneous Activation of the Innate and Adaptive Immune System in Kidney Cancer$259,666
P50 · FY2025 · CA · contact PI
Project 3: Maximizing Anti-tumor Activity through Simultaneous Activation of the Innate and Adaptive Immune System in Kidney Cancer$347,134
P50 · FY2024 · CA · contact PI
Project 3: Maximizing Anti-tumor Activity through Simultaneous Activation of the Innate and Adaptive Immune System in Kidney Cancer$339,344
P50 · FY2023 · CA · contact PI
Real-time prostate lesion tracking during SBRT$351,181
R01 · FY2022 · EB
Project 3: Maximizing Anti-tumor Activity through Simultaneous Activation of the Innate and Adaptive Immune System in Kidney Cancer$332,494
P50 · FY2022 · CA · contact PI
Real-time prostate lesion tracking during SBRT$344,156
R01 · FY2021 · EB
Real-time prostate lesion tracking during SBRT$351,181
R01 · FY2020 · EB
Real-time prostate lesion tracking during SBRT$373,971
R01 · FY2019 · EB